12:00 AM
 | 
Mar 05, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Mylan sales and marketing update

Mylan launched a generic version of escitalopram to treat major depressive disorder (MDD) and acute general anxiety disorder (GAD). Forest Laboratories...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >